These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6800462)

  • 1. Twenty-one years of beating beta-lactamases.
    O'Grady FW
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):369-70. PubMed ID: 6800462
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
    Singhal N; Srivastava A; Kumar M; Virdi JS
    PLoS One; 2014; 10(4):e0123564. PubMed ID: 25919756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactamase inhibitors].
    Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase inactivation by mechanism-based reagents.
    Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of beta-lactamase in penicillinase producing gonococci by clavulanic acid.
    Van Klingeren B; Van Wijngaarden LJ
    J Antimicrob Chemother; 1981 Jul; 8(1):79-80. PubMed ID: 6788749
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clavulanic acid as an inhibitor of beta lactamase].
    Dănilă G
    Rev Med Chir Soc Med Nat Iasi; 1981; 85(2):394. PubMed ID: 6981154
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Lactamase inhibitors--a novel approach.
    Lancet; 1979 Sep; 2(8142):565-6. PubMed ID: 89565
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of clavulanate-amoxicillin synergy using a triple layer technique and enzymatic neutralization.
    Yourassowsky E; Van der Linden MP; Lismont MJ
    Chemotherapy; 1980; 26(3):207-11. PubMed ID: 6988184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
    Matagne A; Ghuysen MF; Frère JM
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):705-11. PubMed ID: 8240281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between non-classical beta-lactam compounds and the beta-lactamases of Actinomadura R39 and Streptomyces albus G.
    Kelly JA; Frère JM; Duez C; Ghuysen JM
    Biochem J; 1981 Oct; 199(1):137-43. PubMed ID: 6978132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.